WO2005082417A1 - Polvo de xilitol directamente comprimible - Google Patents
Polvo de xilitol directamente comprimible Download PDFInfo
- Publication number
- WO2005082417A1 WO2005082417A1 PCT/ES2005/070014 ES2005070014W WO2005082417A1 WO 2005082417 A1 WO2005082417 A1 WO 2005082417A1 ES 2005070014 W ES2005070014 W ES 2005070014W WO 2005082417 A1 WO2005082417 A1 WO 2005082417A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- xylitol
- xylitol powder
- dextrin
- powder according
- dry weight
- Prior art date
Links
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 title claims abstract description 58
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 title claims abstract description 58
- 239000000811 xylitol Substances 0.000 title claims abstract description 58
- 235000010447 xylitol Nutrition 0.000 title claims abstract description 58
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 title claims abstract description 58
- 229960002675 xylitol Drugs 0.000 title claims abstract description 58
- 239000000843 powder Substances 0.000 title claims abstract description 38
- 239000004375 Dextrin Substances 0.000 claims abstract description 23
- 229920001353 Dextrin Polymers 0.000 claims abstract description 23
- 235000019425 dextrin Nutrition 0.000 claims abstract description 23
- 239000000835 fiber Substances 0.000 claims abstract description 20
- 235000013406 prebiotics Nutrition 0.000 claims abstract description 4
- 238000007906 compression Methods 0.000 claims description 12
- 230000006835 compression Effects 0.000 claims description 12
- 239000002537 cosmetic Substances 0.000 claims description 5
- 235000003599 food sweetener Nutrition 0.000 claims description 5
- 239000003765 sweetening agent Substances 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 4
- 235000015097 nutrients Nutrition 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 108010011485 Aspartame Proteins 0.000 claims description 3
- 239000004376 Sucralose Substances 0.000 claims description 3
- 239000000605 aspartame Substances 0.000 claims description 3
- 235000010357 aspartame Nutrition 0.000 claims description 3
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 3
- 229960003438 aspartame Drugs 0.000 claims description 3
- 235000019408 sucralose Nutrition 0.000 claims description 3
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 3
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 2
- 239000004384 Neotame Substances 0.000 claims description 2
- 108010073771 Soybean Proteins Proteins 0.000 claims description 2
- 239000000619 acesulfame-K Substances 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 claims description 2
- 239000004410 anthocyanin Substances 0.000 claims description 2
- 229930002877 anthocyanin Natural products 0.000 claims description 2
- 235000010208 anthocyanin Nutrition 0.000 claims description 2
- 150000004636 anthocyanins Chemical class 0.000 claims description 2
- 229940109275 cyclamate Drugs 0.000 claims description 2
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 claims description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 235000010755 mineral Nutrition 0.000 claims description 2
- ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 claims description 2
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 claims description 2
- 235000019412 neotame Nutrition 0.000 claims description 2
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 claims description 2
- 108010070257 neotame Proteins 0.000 claims description 2
- 239000000419 plant extract Substances 0.000 claims description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 2
- 235000013824 polyphenols Nutrition 0.000 claims description 2
- 239000006041 probiotic Substances 0.000 claims description 2
- 230000000529 probiotic effect Effects 0.000 claims description 2
- 235000018291 probiotics Nutrition 0.000 claims description 2
- 235000019204 saccharin Nutrition 0.000 claims description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 claims description 2
- 229940081974 saccharin Drugs 0.000 claims description 2
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 claims description 2
- 229940001941 soy protein Drugs 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims 1
- 239000000306 component Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 6
- 235000019629 palatability Nutrition 0.000 abstract description 6
- 239000000203 mixture Substances 0.000 description 13
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 10
- 238000005469 granulation Methods 0.000 description 10
- 230000003179 granulation Effects 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 239000011230 binding agent Substances 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 235000013305 food Nutrition 0.000 description 6
- 239000008187 granular material Substances 0.000 description 6
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 5
- 229920001100 Polydextrose Polymers 0.000 description 5
- 208000002925 dental caries Diseases 0.000 description 5
- 239000001259 polydextrose Substances 0.000 description 5
- 235000013856 polydextrose Nutrition 0.000 description 5
- 229940035035 polydextrose Drugs 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 description 4
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 4
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 102000007330 LDL Lipoproteins Human genes 0.000 description 3
- 108010007622 LDL Lipoproteins Proteins 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 208000002064 Dental Plaque Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 235000014755 Eruca sativa Nutrition 0.000 description 1
- 244000024675 Eruca sativa Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920001908 Hydrogenated starch hydrolysate Polymers 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000005141 Otitis Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000181 anti-adherent effect Effects 0.000 description 1
- 230000000170 anti-cariogenic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000000973 cosmetic coloring agent Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000037123 dental health Effects 0.000 description 1
- FYGDTMLNYKFZSV-MRCIVHHJSA-N dextrin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](CO)OC(O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-MRCIVHHJSA-N 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 208000019258 ear infection Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000021197 fiber intake Nutrition 0.000 description 1
- 239000000989 food dye Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000011872 intimate mixture Substances 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000012254 powdered material Substances 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Definitions
- This invention relates to compositions for the manufacture of tablets in the field of the food, cosmetic and pharmaceutical industry.
- Sucrose is the main sweetener used in pharmacy and in the food industry.
- the excessive consumption of sugars is related to various physiological disorders such as obesity and caries development.
- the current trend therefore, is to reduce the excessive consumption of sugars.
- Xylitol As substitutes for sucrose there are products on the market with a caloric value lower than that of sucrose and, in addition, with anticariogenic properties. Among them, xylitol stands out due to its excellent properties.
- Xylitol (formula I) is a natural alcohol that has a sweetening power very similar to that of sucrose and a lower caloric content. Xylitol decreases the incidence of caries, hinders the adhesion of bacteria to dental plaque, contributes to the remineralization of the tooth, and even reverses incipient caries (cf. KK Makinen et al., "Xylitol chewing gums and caries rates: a 40 -month cohort study ", J. Dent. Res.
- xylitol is as a tablet constituent in the pharmaceutical, cosmetic and food fields.
- tablets are used to administer active substances with a suitable size, shape and texture (eg for chewing, sucking, swallowing or dissolving).
- xylitol is used to obtain sweet tablets. Due to its cooling and anti-cryogenic effect, it is also excellent for oral and dental health products.
- Xylitol tablets are usually made by compression or direct molding of the powder previously mixed and prepared for it. In order to use a powder in modern high-production machines, some conditions have to be met. One of them is that the mixture of powders to be compressed must be sufficiently fluid for the powder to correctly fill the molding dies. In addition, the mixture of ingredients must be homogeneous so that all tablets maintain the correct ratio between their ingredients. Xylitol, however, does not have good characteristics to be compressed. It has insufficient flow to work with machines of high production and poor mixing, as it has a tendency to form lumps. The cohesion or compressibility shown by pills made from xylitol is very small, whether the xylitol is in crystalline form or if it is ground and sifted, and the resulting pills do not maintain their commercial quality, easily falling apart.
- Pre-granulation of the powder is usually used to confer powdered materials to be compressed.
- granulation consists of a physical mixing treatment in which a specific binder is added.
- binders have been proposed which, added in the granulation stage, improve the properties of granulated xylitol powder.
- a first attempt is based on the addition of polyols such as sorbitol, mannitol or lactitol (cf. US 5,958,471; US 2003/0039684 and ES 2,041,346).
- polydextrose also have serious limitations for this type of applications.
- One of the most important limitations is that the hardness values of the tablets are the minimum to be able to use industrial machines without compressing the resulting tablets.
- polydextrose are very soluble in water (up to 70-80%), the viscosity of the solutions is very high. This hinders the intimate mixing of the components in the granulation mill.
- polydextrose are hygroscopic, just like CMC, affecting the stability of the tablets once made. Due to the hygroscopicity and viscosity properties mentioned, CMC and polydextrose are more suitable for other applications such as the manufacture of ice cream, sauces, creams and jams.
- the inventors have surprisingly found that the use of dextrin as a binder in xylitol granulation makes it possible to achieve properties of hardness, friability and palatability suitable in tablets made from these granules.
- the present invention provides a granulated and directly compressible xylitol powder comprising xylitol as a major component and dextrin, the dextrin being in a proportion of 1-10% by dry weight.
- dextrin is present in a proportion of 3-5%, and more preferably 3.5% by dry weight.
- Dextrin is a product formed during the course of fractionation of starch to glucose. It owes its name to the property that its solutions have of being intensely dextrogyran to the polarimetric examination, that is, they divert the polarized light to the right. Wheat or corn dextrin with a high soluble fiber content, with a polymerization degree between 12 and 25 is preferred for this invention. In a particular embodiment of the invention, dextrin comprises 60-95% dry weight of Soluble fiber. In another particular embodiment, dextrin comprises 80-90% dry weight of soluble fiber, and more preferably 85% dry weight of soluble fiber.
- a preferred dextrin for this invention is composed of branched glucose chains of between 12 and 25 monomers, where the glycosidic bonds maintain the following proportion: 41% of alpha (1-4), 32% of alpha (1-6), 13 % of alpha (1-2) and 14% of alpha (1-3).
- Fiber is the part of food that is not digested by the body because it lacks the enzymes necessary for its degradation. It is classified as soluble fiber or insoluble fiber, according to its ability to be dissolved in water. Naturally, soluble fiber is found in various cereals, fruits and legumes. Fiber consumption has been shown to reduce cholesterol and LDL levels (low density lipoproteins, "low density lipoproteins") in the blood. In addition, the fiber has the capacity to retain water, increasing the volume of feces and facilitating intestinal transit. Thus, with the use of dextrin as a binder, a granulated and directly compressible xylitol powder is obtained with the healthy properties that fiber provides.
- the preferred xylitol to form the granulate is a sieved milled xylitol of particle size less than 120 microns, but can be split from different grain sizes to get slightly different granules.
- the granulated and directly compressible xylitol powder of the present invention may contain intensive sweeteners or mixtures of intensive sweeteners, such as aspartame, acesulfame K, saccharin and its salts, cyclamate and its salts, neohesperidine dihydrocalcone , thaumatine, neotame and sucralose.
- intensive sweeteners or mixtures of intensive sweeteners such as aspartame, acesulfame K, saccharin and its salts, cyclamate and its salts, neohesperidine dihydrocalcone , thaumatine, neotame and sucralose.
- at least one nutrient selected from the group consisting of vitamins, minerals, anthocyanins, polyphenols, soy protein, plant extracts and amino acids is added to the granulated xylitol powder.
- At least one food or cosmetic dye is added, both authorized by the applicable legislation.
- at least one nutrient considered prebiotic and / or probiotic is added.
- at least one pharmaceutical active ingredient and / or a cosmetic active ingredient is added (mouth and tooth care products are considered cosmetic in this invention).
- the granulation of the xylitol powder of the present invention is carried out with the conventional granulation methods known to those skilled in the art.
- the present invention also relates to obtaining tablets or tablets resulting from the compression of the granulated and directly compressible xylitol powder described above.
- the tablets may be chewable, effervescent, coated, delayed release, multilayer, etc.
- the tablets are made directly by compression of the powder previously mixed and prepared for it.
- the compression can be broken down into three stages: filling of the molding matrix, compression (single or double), and ejection of the tablet.
- the correct filling of the dies depends on the correct flow of the powder to be compressed, and on the speed of the compression machine. Compression parameters are adjusted according to the weight and diameter of the tablet, while the ejection requires the correct lubrication of the powder mixture, generally, by adding some lubricant in the mixture in the necessary amount.
- the granulated and directly compressible xylitol powder of the invention has very good compression properties.
- the density of high soluble fiber dextrin is low enough in solutions of up to 60% by weight to allow proper spraying on the xylitol in the granulation mill. Thus an intimate mixture is achieved in the mill.
- the flow properties in the compression machine are improved.
- the tablets made from the powder reach significantly higher hardness values and lower friability. The tablets maintain the desired sweetness as well as all the healthy properties of xylitol and the prebiotic effect of the fiber.
- the term “hardness” refers to the force that the tablet is able to withstand until it breaks.
- the term “friability” refers to the amount of dust that is released by friction.
- binder is meant a material capable of joining fragments of one or more substances and giving cohesion to the whole by exclusively physical effects.
- tablet, tablet and tablet are used with the same meaning.
- the xylitol to form the granulate is a sieved milled xylitol of particle size less than 120 microns.
- the binder used is Nutrióse ® FB dextrin (Roquette) with a high soluble fiber content (85% fiber soluble according to the method "AOAC official method 2001.03").
- Xylitol powder was used in a vertical mixer continuously granulating the back mix, at a flow of 1000 kg / h.
- the 60% Nutrióse ® FB solution it was injected at 100 liters / hour on a mixer that rotated at 3200 rpm.
- the resulting product, after sieving, was dried in a four-stage oven at 60 ° C, 45 ° C, and between 20 ° C and 25 ° C in the last two stages.
- the resulting product was screened and its humidity was less than 0.5%, while its apparent density was 0.72-0.76 g / ml.
- the flow obtained was adequate for high production compressing machines.
- Lubricant (hydrogenated vegetable oil powder) 1.0% Aspartame 0.6%
- the granulate obtained exhibited excellent flow and compressibility using a standard high production compressor equipment such as the Fette P3090. Tablets of 7.5 mm in diameter, 4.5 mm in height and 200 mg in weight were obtained, at productivities of 350,000 units / hour.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05708111A EP1721620A1 (en) | 2004-02-17 | 2005-02-10 | Directly-compressible xylitol powder |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ESP200400453 | 2004-02-17 | ||
ES200400453A ES2242523B1 (es) | 2004-02-17 | 2004-02-17 | Polvo de xilitol directamente comprimible. |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005082417A1 true WO2005082417A1 (es) | 2005-09-09 |
Family
ID=34896225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/ES2005/070014 WO2005082417A1 (es) | 2004-02-17 | 2005-02-10 | Polvo de xilitol directamente comprimible |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1721620A1 (es) |
ES (1) | ES2242523B1 (es) |
WO (1) | WO2005082417A1 (es) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007061860A1 (en) * | 2005-11-23 | 2007-05-31 | The Coca-Cola Company | High-potency sweetener composition with probiotics/prebiotics and compositions sweetened therewith |
US8017168B2 (en) | 2006-11-02 | 2011-09-13 | The Coca-Cola Company | High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith |
US9101160B2 (en) | 2005-11-23 | 2015-08-11 | The Coca-Cola Company | Condiments with high-potency sweetener |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR058580A1 (es) | 2006-12-20 | 2008-02-13 | Makuc Ruben Antonio | Particulas solidas comprimibles , procedimientos para obtenerlas y procedimientos para utilizar las particulas solidas en tabletas o comprimidos para la higiene corporal |
CN102429885B (zh) * | 2011-12-30 | 2013-05-08 | 山东力诺科峰制药有限公司 | 一种可直接压片的木糖醇及其制备方法 |
JP2019511249A (ja) * | 2016-03-31 | 2019-04-25 | トゥッティフーディ・ベスローテン・フェンノートシャップ | 顆粒 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5204115A (en) * | 1990-12-12 | 1993-04-20 | Suomen Xyrofin Oy | Directly compressible xylitol and method |
US5385749A (en) * | 1990-12-14 | 1995-01-31 | Roquette Freres | Directly compressible pulverulent composition and a process for obtaining the same |
US6010717A (en) * | 1994-09-27 | 2000-01-04 | Arends-Scholte; Anna Willemina | Starch products as tabletting excipient, method for preparing same, and method for making tablets |
US20030039684A1 (en) * | 1997-10-15 | 2003-02-27 | Eugen Schwarz | Preparation of a directly mouldable tabletting auxiliary |
-
2004
- 2004-02-17 ES ES200400453A patent/ES2242523B1/es not_active Expired - Fee Related
-
2005
- 2005-02-10 WO PCT/ES2005/070014 patent/WO2005082417A1/es not_active Application Discontinuation
- 2005-02-10 EP EP05708111A patent/EP1721620A1/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5204115A (en) * | 1990-12-12 | 1993-04-20 | Suomen Xyrofin Oy | Directly compressible xylitol and method |
US5385749A (en) * | 1990-12-14 | 1995-01-31 | Roquette Freres | Directly compressible pulverulent composition and a process for obtaining the same |
US6010717A (en) * | 1994-09-27 | 2000-01-04 | Arends-Scholte; Anna Willemina | Starch products as tabletting excipient, method for preparing same, and method for making tablets |
US20030039684A1 (en) * | 1997-10-15 | 2003-02-27 | Eugen Schwarz | Preparation of a directly mouldable tabletting auxiliary |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007061860A1 (en) * | 2005-11-23 | 2007-05-31 | The Coca-Cola Company | High-potency sweetener composition with probiotics/prebiotics and compositions sweetened therewith |
US8524304B2 (en) | 2005-11-23 | 2013-09-03 | The Coca-Cola Company | High-potency sweetener composition with probiotics/prebiotics and compositions sweetened therewith |
US9101160B2 (en) | 2005-11-23 | 2015-08-11 | The Coca-Cola Company | Condiments with high-potency sweetener |
US8017168B2 (en) | 2006-11-02 | 2011-09-13 | The Coca-Cola Company | High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith |
Also Published As
Publication number | Publication date |
---|---|
ES2242523B1 (es) | 2006-12-01 |
ES2242523A1 (es) | 2005-11-01 |
EP1721620A1 (en) | 2006-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2273510T3 (es) | Procedimiento para preparar composiciones orales de calcio. | |
ES2302926T5 (es) | Cápsula blanda masticable | |
US5204115A (en) | Directly compressible xylitol and method | |
US6432442B1 (en) | Chewable product | |
ES2834394T3 (es) | Procedimiento de fabricación de formas dosificables de comprimidos masticables para el suministro de fármacos y productos de los mismos | |
ES2236768T3 (es) | Comprimido masticable, en grageas, soluble, que contiene goma. | |
US8062659B2 (en) | Dietary fiber composition | |
US20090169682A1 (en) | Functional Masticatory Material, Method Of Producing The Same And Method Of Using The Same | |
ES2686081T3 (es) | Dextrosa comprimible directamente | |
PT93452B (pt) | Processo para a preparacao de uma pastilha de colestiramina | |
SA112340044B1 (ar) | تركيب صيدلاني يشتمل على أكسي هيدروكسيد الحديد بحمولة عالية على شكل ملائم للإعطاء عن طريق الفم | |
JP2005527591A (ja) | 機能性成分の送達システム | |
WO2005082417A1 (es) | Polvo de xilitol directamente comprimible | |
CN104382868B (zh) | 口腔可分散的甘露醇 | |
US20070178150A1 (en) | Pharmaceutical compositions | |
JP4689468B2 (ja) | 錠剤およびその製造方法 | |
PL184869B1 (pl) | Środek przeczyszczający i sposób wytwarzania środka przeczyszczającego | |
PL210931B1 (pl) | Kompozycja w postaci stałej nadająca się do połykania zawierająca alginian, wodorowęglan i/lub węglan, jej zastosowanie oraz sposób wytwarzania | |
US20120034302A1 (en) | Particulate composition and the method of making the same | |
JP2007246541A (ja) | 機能性咀嚼物及びその製造方法 | |
US7182964B2 (en) | Dissolving thin film xanthone supplement | |
US20220110900A1 (en) | Solid nutrient compositions and associated methods | |
JP2002154949A (ja) | 内服用固形製剤 | |
Pundir et al. | Oral disintegrating preparation-medicated chewing gum | |
ES2625889T3 (es) | Proceso de compresión de lsomalt |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005708111 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
WWP | Wipo information: published in national office |
Ref document number: 2005708111 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2005708111 Country of ref document: EP |